<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00769275</url>
  </required_header>
  <id_info>
    <org_study_id>DIAD</org_study_id>
    <secondary_id>HIC #11312</secondary_id>
    <nct_id>NCT00769275</nct_id>
  </id_info>
  <brief_title>Detection of Ischemia in Asymptomatic Diabetics</brief_title>
  <acronym>DIAD</acronym>
  <official_title>Detection of Ischemia in Asymptomatic Diabetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Astellas Pharma US, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asymptomatic subjects with Type 2 Diabetes Mellitus were randomized to either screening with
      Tc-99m sestamibi adenosine SPECT imaging or no screening. All patients will be followed for 5
      years for the occurrence of cardiac death or non-fatal myocardial infarction.

      The aims are:

        1. To prospectively assess the prevalence of silent myocardial ischemia in asymptomatic
           subjects with Type 2 Diabetes Mellitus.

        2. To identify on the basis of clinical and/or biochemical variables in a high-risk cohort
           in which screening for coronary artery disease is appropriate.

        3. To assess progression of (silent) myocardial ischemia after 3 years.

        4. To assess the occurence of cardiac death or nonfatal myocardial infarction during 5
           years follow-up in screened and not screened subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2000</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of silent myocardial ischemia in subjects randomized to screening was 22%.</measure>
    <time_frame>At study entry</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>At repeat stress imaging three years after recruitment 79% of subjects showed resolution of ischemia, whereas only 10% developed new ischemia.</measure>
    <time_frame>3 years after start</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall cardiac event rate (cardiac death, myocardial infarction) was 3.0%, not different in screened and not screened cohort</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1123</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Screening at start study with Adenosine vasodilator stress Tc-99m Sestamibi SPECT imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>No screening</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Asymptomatic patients with type 2 diabetes mellitus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50-75 years

          -  Type 2 diabetes mellitus

        Exclusion Criteria:

          -  Angina or anginal equivalent

          -  Abnormal rest ECG (Q or ST depression)

          -  Known CAD

          -  Stress testing within the last 3 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frans J Wackers, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE; Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004 Aug;27(8):1954-61. Erratum in: Diabetes Care. 2005 Feb;28(2):504.</citation>
    <PMID>15277423</PMID>
  </reference>
  <reference>
    <citation>Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE; Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care. 2007 Nov;30(11):2892-8. Epub 2007 Aug 6.</citation>
    <PMID>17682123</PMID>
  </reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2008</study_first_submitted>
  <study_first_submitted_qc>October 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2008</study_first_posted>
  <last_update_submitted>October 8, 2008</last_update_submitted>
  <last_update_submitted_qc>October 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Frans J Th Wackers, MD, PhD</name_title>
    <organization>Yale University School of Medicine</organization>
  </responsible_party>
  <keyword>silent ischemia</keyword>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>screening</keyword>
  <keyword>cardiac outcome</keyword>
  <keyword>Prevalence silent myocardial ischemia</keyword>
  <keyword>Cardiac outcome in screened and not-screened subjects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

